Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 14 of 35

COMPLETED Early Phase 1

Ertugliflozin: Cardioprotective Effects on Epicardial Fat

NCT04167761

COMPLETED

Predicting Endometrial Receptivity for Optimal Reproductive Management

NCT04107129

COMPLETED NA

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D - 4T Study

NCT04336969

COMPLETED NA

Electronic Intervention to Chronic Opioid Therapy

NCT04198961

COMPLETED NA

Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic

NCT04409743

COMPLETED NA

Psychophysiological Effects of Controlled Respiration and Mindfulness

NCT05304000

TERMINATED Phase 3

ARrest RESpiraTory Failure From PNEUMONIA

NCT04193878

COMPLETED Phase 2

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

NCT04380337

COMPLETED NA

Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder

NCT04268316

COMPLETED Phase 2

Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19

NCT04331899

COMPLETED NA

Improving Access to Pivotal Response Treatment (PRT) Via Telehealth Parent Training

NCT04042337

COMPLETED

Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19

NCT04373148

COMPLETED

Predicting Outcomes for Covid-19 Using Sonography

NCT04384055

COMPLETED

COVID-19 in Patients With Chronic Liver Diseases

NCT04439084

COMPLETED

Serratus Anterior Plane Block for Improving Pain and Respiratory Function in Patients With Multiple Rib Fractures

NCT04311827

COMPLETED NA

Peer-Led Dissonance Eating Disorder Prevention: Virtual Delivery

NCT04433247

COMPLETED NA

Respiratory Disorders Non-invasive Monitoring of Work of Breathing in Outpatients

NCT04003415

COMPLETED

Biologically Focused Therapy of Treatment-Refractory MDS Patients

NCT05245032

TERMINATED Phase 4

Continuous Intravenous Lidocaine Infusion Versus Placebo for Rib Fracture Analgesia

NCT04140396

COMPLETED Phase 2

Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)

NCT03679676

COMPLETED NA

The Utility of Virtual Reality in the Management of Pediatric Functional Constipation With Pelvic Floor Dysfunction.

NCT04172948

TERMINATED

Social Anxiety Virtual Reality Study

NCT04288180

COMPLETED NA

Imaginal Exposure for Hoarding Disorder

NCT03734705

COMPLETED NA

Pilot Study of a Decision Aid Intervention for Family-building After Cancer

NCT04059237

COMPLETED Phase 4

Impact of Plant Sterol Supplement on LDL-C Lowering in Low-to-Moderate Risk South Asian Patients

NCT04030247

COMPLETED NA

Study to Improve Survivorship Care Related to Fertility and Family-building After Cancer

NCT04200287

COMPLETED NA

Effects of an Educational Planetary Plate Graphic on Meat Consumption

NCT05565859

COMPLETED NA

Effects of an Intermittent Reduced Calorie Diet on Crohn's Disease

NCT04147585

COMPLETED NA

Engaging Patients to Help Achieve Increased Patient Choice and Engagement for AFib Stroke Prevention

NCT04096781

COMPLETED

Immune and Physical Recovery Following Cesarean Delivery

NCT04358757

COMPLETED NA

Evaluation of Objective Pain Measurement Device

NCT03975660

TERMINATED NA

Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder

NCT04058249

COMPLETED NA

Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait Using Neural and Kinematic Feedback

NCT04043403

COMPLETED Phase 1

The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets

NCT03898986

COMPLETED NA

Piloting a Mobile Game for Behavioral Therapy

NCT04450641

TERMINATED NA

Feasibility Study to Improve AF Outcomes Using a Digital Application for CV Risk Reduction

NCT04050982

COMPLETED NA

Clinical Reminder to Improve Appropriateness of Echocardiography

NCT04925245

TERMINATED Phase 1

Response to Influenza Vaccine During Pregnancy

NCT03888989

COMPLETED NA

Single Session Class to Reduce Opioid Use in Chronic Pain

NCT03950791

TERMINATED NA

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

NCT04077372

COMPLETED NA

Validating the New Remote Hypnotic Induction Profile (rHIP)

NCT04058483

COMPLETED

Evaluation of Headache and Childbirth in a Chronic Pain Population

NCT04632420

COMPLETED

Association Between Chronic Headache and Back Pain With Childbirth

NCT04091321

COMPLETED Phase 1

Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies

NCT04088890

COMPLETED NA

Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating

NCT03687658

COMPLETED Phase 4

Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate

NCT04006925

COMPLETED NA

Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion

NCT04095624

TERMINATED NA

Choice of Modality of Follow up for Medication Abortion

NCT04056637

COMPLETED NA

Me-GC: A Randomized Controlled Trial of Meditation for Genetic Counselors

NCT03723018

COMPLETED NA

Utilizing a 3D Printed Model of the Mediastinum to Teach Thoracic Anatomy to Medical Trainees

NCT05040100

← Previous Page 14 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.